Thalidomide-Induced IgA Vasculitis in a Post-Autologous Stem Cell Transplant Recipient
- PMID: 38174292
- PMCID: PMC10752409
- DOI: 10.4103/ijn.ijn_55_23
Thalidomide-Induced IgA Vasculitis in a Post-Autologous Stem Cell Transplant Recipient
Conflict of interest statement
There are no conflicts of interest.
Figures


References
-
- Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch-Shönlein purpura) in adults:Diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14:579–85. - PubMed
-
- Rigante D, Castellazzi L, Bosco A, Esposito S. Is there a crossroad between infections, genetics, and Henoch–Schönlein purpura? Autoimmun Rev. 2013;12:1016–21. - PubMed
-
- Yildirim ND, Ayer M, Küçükkaya RD, Alpay N, Mete O, Yenerel MN, et al. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma. Jpn J Clin Oncol. 2007;37:704–7. - PubMed
-
- Neben K, Moehler T, Benner A, Kraemer A, Egerer G, Ho AD, et al. Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma. Clin Cancer Res. 2002;8:3377–82. - PubMed
-
- Hetland L, Susrud K, Lindahl K, Bygum A. Henoch-Schönlein purpura:A literature review. Acta Derm Venereol. 2017;97:1160–6. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous